SEARCH

SEARCH BY CITATION

References

  • 1
    Anonymous. Organ procurement and transplantation network—HRSA. Final rule with comment period. Federal Register 1998; 63:1629616338. MEDLINE
  • 2
    Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999:5778.
  • 3
    Freeman R, Edwards E. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy. Liver Transpl 2000; 6:543552. MEDLINE
  • 4
    Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3:628637. MEDLINE
    Direct Link:
  • 5
    Child CG II, Turcotte JG. Surgery and portal hypertension. In: ChildCGIII (ed) The liver and portal hypertension. Philadelphia: Saunders, 1964:5058.
  • 6
    Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1:673676. MEDLINE
  • 7
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646649. MEDLINE
  • 8
    Christensen E, Schlichting P, Fauerholdt L, Gluud C, Anderson PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1983; 3:889895. MEDLINE
  • 9
    Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7:660664. MEDLINE
  • 10
    Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25:10491053. MEDLINE
  • 11
    Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999; 29:16431648. MEDLINE
  • 12
    Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Fernandez-Banares F, Esteve M, Planas R, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of the Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993; 88:382389. MEDLINE
  • 13
    Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34:4652. MEDLINE
  • 14
    Moroto A, Gines A, Salo J, Claria J, Gines P, Anibarro L, et al. Diagnosis of functional renal failure of cirrhosis by Doppler sonography. Prognostic value of resistive index. Hepatology 1994; 20:839844. MEDLINE
  • 15
    Gines P, Fernandez Esparrach SG. Prognosis of cirrhosis with ascites. In: ArroyoV, GinesP, RodesJ, SchrierRW (eds). Ascites and renal dysfunction in liver disease. Oxford, UK: Blackwell Science, 1999:431441.
  • 16
    United Network for Organ Sharing. Policy 3.6. Allocation of livers. Available at: www.unos.org. Accessed: October 13, 2000.
  • 17
    Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network—Transplant Data 1990–1999. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2000.
  • 18
    Robert A, Chazoulleres O. Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24:13921394. MEDLINE
  • 19
    Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10:17. MEDLINE
  • 20
    Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100:17101717. MEDLINE
  • 21
    Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: Natural history, prognostic factors, and survival analysis. Hepatology 1989; 10:430436. MEDLINE
  • 22
    Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology 1983; 3:896905. MEDLINE
  • 23
    Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Ranin L. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 86:210216. MEDLINE
  • 24
    Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: Clinical presentation and use of prognostic index. Gut 1986; 27:13771381. MEDLINE
  • 25
    Schenker S. Alcoholic liver disease: Evaluation of natural history and prognostic factors. Hepatology 1984; 4:S36S43.
  • 26
    Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75:193199. MEDLINE
  • 27
    Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21:163174. MEDLINE
  • 28
    D'Amico G, Marabito A, Pagliaro L, Marubini E, and the Liver Study Group. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31:468475. MEDLINE
  • 29
    Gines P, Quintero E, Arroyo V, Teres J, Burguera M, Rimola A, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7:122128. MEDLINE
  • 30
    Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24:269276. MEDLINE
  • 31
    Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, et al. Aminopyrine breath test in prognostic evaluation of patients with cirrhosis. Gut 1992; 33:836842. MEDLINE
  • 32
    Beuers U, Jager F, Wahllander A, Ansari H, Kirsch CM. Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 1991; 50:212218. MEDLINE
  • 33
    Arrigoni A, Gindro T, Aimo G, Capello N, Meloni A, Benedetti P, et al. Monoethylglycinexylidide test: A prognostic indicator of survival in cirrhosis. Hepatology 1994; 20:383387. MEDLINE
  • 34
    Oellerich M, Burdelski M, Lautz H-U, Binder L, Pichlmayr R. Predictors of one year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14:10291034. MEDLINE
  • 35
    Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J Hepatol 1996; 25:474480. MEDLINE
  • 36
    Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988; 6:350358. MEDLINE
  • 37
    Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981; 94:198201. MEDLINE
  • 38
    Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ, Goldman L, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997; 113:12781288. MEDLINE
  • 39
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, terBorg PL. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864871. MEDLINE
  • 40
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464470. MEDLINE
  • 41
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:2936. MEDLINE
  • 42
    Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl 2000; 6:753758. MEDLINE
  • 43
    Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal variceal detection? Hepatology 2001; 33:333338. MEDLINE
  • 44
    Arroyo V, Gines P, Gerbes A, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164176. MEDLINE
  • 45
    Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890895. MEDLINE
  • 46
    Graham D, Smith J. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800806. MEDLINE
  • 47
    Altman C, Grange JD, Amiot X, Pelletier G, Lacaine F, Bodin F, et al. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. J Gastroenterol Hepatol 1995; 10:4750. MEDLINE
  • 48
    Garrett KO, Reilly JJ, Schade RR, Van Thiel DW. Sclerotherapy of esophageal varices: Long-term results and determinants of survival. Surgery 1988; 104:813818. MEDLINE
  • 49
    DiMagno EP, Zinsmeister AR, Larson DE, Viggiano TR, Clain JE, Laughlin BL, et al. Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: A retrospective analysis. Mayo Clin Proc 1985; 60:149157. MEDLINE
  • 50
    Milliken WJ, Warren DW, Henderson JM, Smith RB, Salam AA, Galambos JT, et al. The Emory prospective randomized trial: Selective versus nonselective shunt to control variceal bleeding: Ten year follow-up. Ann Surg 1985; 201:712722. MEDLINE
  • 51
    Everhart JE, Bereford TP. Liver transplantation for alcoholic liver disease: A survey of transplantation in the United States. Liver Transpl Surg 1997; 3:220226. MEDLINE
    Direct Link:
  • 52
    Kim WR, Wiesner RH, Therneau T, Poterucha JJ, Porayko ME, Evans RW, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998; 28:3538.
  • 53
    Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30:11211127. MEDLINE
  • 54
    Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000; 31:711. MEDLINE
  • 55
    Mayo PSC Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336:690695.
  • 56
    Wiesner RH, Edwards EB, Kamath PS, Kim WR, Kremers WK, Freeman RB, et al. Mayo end-stage liver disease model (MELD) score predicts liver transplant waiting list mortality: Implications for liver allocation policy [abstract]. Transplantation 2001; 71(suppl 1):461.
  • 57
    Freeman RB, Rohrer RS, Katz E, Lewis WD, Jenkin R, Cosimi AB, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 2001; 7:173178. MEDLINE
  • 58
    McDiarmid S. 2000 Report of the Studies of Pediatric Liver Transplantation (SPLIT). Potomac, MD, EMMES Corp, 2000.
  • 59
    McDiarmid SV, Anand R, and SPLIT Research Group. Development of a pediatric end-stage liver disease score [abstract]. Transplantation 2001; 71(suppl 1):461.
  • 60
    Swaminathan R, Major P, Snieder H, Spector T. Serum creatinine and fat-free mass (lean body mass). Clin Chem 2000; 46:16951696. MEDLINE
  • 61
    Cockroft RW, Gault MN. Prediction of creatinine clearance from creatinine. Nephron 1976; 16:3141. MEDLINE
  • 62
    Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5:192199. MEDLINE
  • 63
    Mazzafero V, Regalia V, Doci E, Andreola S, Purvirent A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693699. MEDLINE
  • 64
    Kim WR, Wiesner RH, Kamath PS, Malinchoc M, Kremers WK, Rosen CB, et al. Prediction of liver transplant outcome using the MELD scale [abstract]. Transplantation 2001; 71(suppl 1):284.